The authors of the Report are:
Christopher R. Deubert is the Senior Law and Ethics Associate for the Law and Ethics Initiative of the Football Players Health Study at Harvard University. Previously, Deubert practiced commercial litigation, sports law, securities litigation, and labor/employment litigation at Peter R. Ginsberg Law, LLC f/k/a Ginsberg & Burgos, PLLC in New York City. His sports practice focused primarily on representing NFL players in League matters, including appeals for Commissioner Discipline, under the NFL’s Policy and Program on Substances of Abuse and under the NFL’s Policy on Anabolic Steroids and Related Substances (now known as the Policy on Performance-Enhancing Substances), and related litigation. Deubert also previously worked for Sportstars, Inc., one of the largest NFL-player representation firms, performing contract, statistical, and legal analysis, and he performed similar work during an internship with the New York Jets. Deubert graduated with a joint J.D./M.B.A. degree from Fordham University School of Law and Graduate School of Business in 2010, and a B.S. in Sport Management from the University of Massachusetts in 2006.
Disclosure: Deubert’s salary is fully supported by the Football Players Health Study at Harvard University. From August 2010 to May 2014, Deubert was an associate at the law firm of Peter R. Ginsberg Law, LLC f/k/a Ginsberg & Burgos, PLLC. During the course of his practice at that firm, Deubert was involved in several legal matters in which the NFL was an opposing party, including several discussed in this Report. The matters discussed in this Report include the representation of: a former NFL player interested in seeking benefits pursuant to the proposed settlement in the Concussion Litigation, discussed at length in Chapter 7: The NFL and NFLPA; players disciplined pursuant to the NFL’s Policy and Program on Substances of Abuse and the Policy on Anabolic Steroids and Related Substances (now known as the Policy on Performance-Enhancing Substances), discussed in Chapter 7: The NFL and NFLPA; Kevin Williams and Pat Williams in the “StarCaps” case, discussed in Chapter 7: The NFL and NFLPA; and, Jonathan Vilma in the “Bounty”-related legal proceedings, discussed at length in Chapter 9: Coaches. Deubert also was involved in the representation of former Miami Dolphins offensive line coach Jim Turner in the Jonathan Martin-“bullying” situation, discussed at length in Chapter 9: Coaches, which was the result of an NFL investigation but did not involve litigation with the NFL. Additionally, Deubert was also involved in the representation of both Contract Advisors and players in litigation and arbitrations under the NFLPA’s Regulations Governing Contract Advisors, discussed at length in Chapter 12: Contract Advisors. Lastly, since 2007, Deubert has provided research assistance to the Sports Lawyers Association, whose Board of Directors includes many individuals with interests related to this work.
Glenn Cohen is a professor at Harvard Law School, Faculty Director of the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics, and Co-Lead of the Law and Ethics Initiative of the Football Players Health Study. His award-winning work at the intersection of law, medicine, and ethics – in particular, medical tourism and assisted reproduction – has been published in leading journals, such as the Harvard Law Review, Stanford Law Review, New England Journal of Medicine, Journal of the American Medical Association, American Journal of Bioethics, and American Journal of Public Health. He was previously a fellow at the Radcliffe Institute for Advanced Study and a faculty scholar in bioethics with the Greenwall Foundation. He is the author, editor, and/or co-editor of several books from Oxford, Columbia, John Hopkins, and MIT University Presses. Prior to joining the Harvard faculty, Cohen served as a clerk to Chief Judge Michael Boudin, United States Court of Appeals for the First Circuit, and as an appellate lawyer in the Civil Division of the Department of Justice. He graduated from the University of Toronto with a B.A. (with distinction) in Bioethics (Philosophy) and Psychology and earned his J.D. from Harvard Law School.
Disclosure: 20 percent of Cohen’s salary is supported by the Football Players Health Study at Harvard University. Cohen has no other conflicting interests to report.
Holly Fernandez Lynch is Executive Director of the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics, Faculty at the Harvard Medical School Center for Bioethics, and Co-Lead of the Law and Ethics Initiative of the Football Players Health Study. Her scholarly work focuses on the regulation and ethics of human subjects’ research and issues at the heart of the doctor-patient relationship. Her book, Conflicts of Conscience in Health Care: An Institutional Compromise, was published by MIT Press in 2008; she is also co-editor with I. Glenn Cohen of Human Subjects Research Regulation: Perspectives on the Future (MIT Press 2014) and FDA in the 21st Century: The Challenges of Regulating Drugs and New Technologies (Columbia University Press 2015). Lynch practiced pharmaceuticals law at Hogan & Hartson, LLP (now Hogan Lovells), in Washington, D.C., and worked as a bioethicist in the Human Subjects Protection Branch at the National Institutes of Health’s Division of AIDS. She served as senior policy and research analyst for President Obama’s Commission for the Study of Bioethical Issues. Lynch is currently a member of the Secretary’s Advisory Committee on Human Research Protections at the U.S. Department of Health and Human Services. She graduated Order of the Coif from the University of Pennsylvania Law School, where she was a Levy Scholar in Law and Bioethics. She earned her master’s degree in bioethics from the University of Pennsylvania’s School of Medicine, and her B.A. with a concentration in bioethics, also from the University of Pennsylvania.
Disclosure: 30 percent of Lynch’s salary is supported by the Football Players Health Study at Harvard University. Lynch has no other conflicting interests to report.